VisaSeq Breast and GYN Cancer Panel
Clinical Genetic Test
offered by
GTR Test Accession: Help GTR000556509.3
Last updated in GTR: 2019-05-13
Last annual review date for the lab: 2023-07-26 LinkOut
At a Glance
Diagnosis; Pre-symptomatic; Risk Assessment
Familial cancer of breast; Adrenocortical carcinoma, hereditary; Ataxia-telangiectasia-like disorder; ...
ABRAXAS1 (4q21.23), ATM (11q22.3), BARD1 (2q35), BRCA1 (17q21.31), BRCA2 (13q13.1), ...
Molecular Genetics - Deletion/duplication analysis: Comparative Genomic Hybridization; Multiplex Ligation-dependent Probe Amplification (MLPA); ...
Patients with a family history consistent with an inherited cancer …
Not provided
Not provided
Ordering Information
Offered by: Help
Molecular Diagnostic Laboratory
View lab's website
Specimen Source: Help
Test Order Code: Help
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 32
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 25
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Total methods: 3
Method Category Help
Test method Help
Instrument *
Deletion/duplication analysis
Comparative Genomic Hybridization
Deletion/duplication analysis
Multiplex Ligation-dependent Probe Amplification (MLPA)
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Pre-symptomatic; Risk Assessment
Target population: Help
Patients with a family history consistent with an inherited cancer syndrome
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
The sensitivity of NGS/MPS is over 99% for the detection of single nucleotide variants, and over 85% for small/large deletions and insertions in the regions analyzed, the sensitivity of MLPA analysis is over 95% for the detection of deletions and duplications of complete exons in the regions analyzed, and the … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.